Myriad Genetics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -2.8% | -2.8% | -2.1% |
| FY2022 | -12.6% | -12.6% | -9.3% |
| FY2023 | -33.6% | -32.0% | -23.0% |
| FY2024 | -18.2% | -17.2% | -12.4% |
| FY2025 | -99.4% | -75.0% | -51.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -2.8% | -2.8% | -2.1% |
| FY2022 | -12.6% | -12.6% | -9.3% |
| FY2023 | -33.6% | -32.0% | -23.0% |
| FY2024 | -18.2% | -17.2% | -12.4% |
| FY2025 | -99.4% | -75.0% | -51.8% |